Novo’s Blockbuster Obesity Drug Still Hit by US Bottlenecks

Tainted Medication Fears Spur US Defense Department to Seek Outside Testing

A $2.8 Million Miracle Therapy Eludes Some Long-Suffering Patients

Weight-Loss Stocks Soar After Obesity-Drug Study Spurs Investor Frenzy

Bayer’s New CEO Says Nothing Off Table in Strategic Review

Obesity Drug Wegovy Cuts Risk of Heart Attacks and Strokes by 20%, Study Shows

Bayer Lowers Revenue Forecasts for Crops and Drugs Units

Elon Musk's Neuralink Raises $280 Million to Develop Brain Implants

Biotech Firm Vistagen Surges 1,370% on Social Anxiety Spray Trial Success

Tinseltown Troubles Torment Studios: Earnings Week Ahead

Sage Tumbles as Depression Pill Approval Omits Major Disorder

Rakuten’s Mikitani Spends a Fifth of His Time on Biotech Startup